array(40) {
  [0]=>
  string(4) "8306"
  ["article_id"]=>
  string(4) "8306"
  [1]=>
  string(61) "Surgery Superior to Nonoperative Care for Persistent Sciatica"
  ["article_title"]=>
  string(61) "Surgery Superior to Nonoperative Care for Persistent Sciatica"
  [2]=>
  string(150) "WEDNESDAY, March 18, 2020 -- Microdiscectomy is superior to nonsurgical care with respect to pain intensity in patients with sciatica lasting more tha"
  ["short_description"]=>
  string(150) "WEDNESDAY, March 18, 2020 -- Microdiscectomy is superior to nonsurgical care with respect to pain intensity in patients with sciatica lasting more tha"
  [3]=>
  string(251) "WEDNESDAY, March 18, 2020 -- Microdiscectomy is superior to nonsurgical care with respect to pain intensity in patients with sciatica lasting more than four months and caused by lumbar disc herniation, according to a study published in the March 19..."
  ["description"]=>
  string(251) "WEDNESDAY, March 18, 2020 -- Microdiscectomy is superior to nonsurgical care with respect to pain intensity in patients with sciatica lasting more than four months and caused by lumbar disc herniation, according to a study published in the March 19..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(197) "https://www.drugs.com/news/surgery-superior-nonoperative-care-persistent-sciatica-89045.html?utm_source=ddc&utm_medium=rss&utm_campaign=Surgery+Superior+to+Nonoperative+Care+for+Persistent+Sciatica"
  ["blog_url"]=>
  string(197) "https://www.drugs.com/news/surgery-superior-nonoperative-care-persistent-sciatica-89045.html?utm_source=ddc&utm_medium=rss&utm_campaign=Surgery+Superior+to+Nonoperative+Care+for+Persistent+Sciatica"
  [15]=>
  string(19) "2020-03-19 03:00:19"
  ["add_date"]=>
  string(19) "2020-03-19 03:00:19"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:28:42"
  ["create_at"]=>
  string(19) "2020-03-19 11:28:42"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8426"
  ["article_id"]=>
  string(4) "8426"
  [1]=>
  string(57) "What If We Couldn't Sue Our Doctors for Malpractice?"
  ["article_title"]=>
  string(57) "What If We Couldn't Sue Our Doctors for Malpractice?"
  [2]=>
  string(153) "&#nlDuring childbirth, are doctors more likely or less likely to intervene surgically if liability is a concern? A study co-authored by an ec"
  ["short_description"]=>
  string(153) "&#nlDuring childbirth, are doctors more likely or less likely to intervene surgically if liability is a concern? A study co-authored by an ec"
  [3]=>
  string(3976) "&#nl
During childbirth, are doctors more likely or less likely to intervene surgically if liability is a concern? A study co-authored by an economist at Massachusetts of Technology (MIT) and a professor of law and economics at the Duke University, offers insight on this interesting question about "defensive medicine."
&#nl
The research, based on evidence from the U.S. Military Health System, finds that when doctors have immunity from liability lawsuits, they actually perform slightly more C-section operations, compared to when they are legally liable for those operations — about 4% more, over a 10-year period.
&#nl
“When you’re worried about errors of commission, defensive medicine can lead to [less] treatment of patients,” said Jonathan Gruber, an MIT economist and co-author of a new paper detailing the study’s findings.
&#nl
The paper, “Defensive Medicine and Obstetric Practices: Evidence from the Military Health System,” is published this month in the Journal of Empirical Legal Studies. Gruber's co-author is Michael Frakes, a professor of law and economics at the Duke University School of Law.
&#nl
According to the paper, 74% of obstetricians and gynecologists face malpractice claims by age 45, compared to 55% of physicians in the area of internal medicine.
&#nl
To conduct the study, Gruber and Frakes used Military Health System data to conduct what economists call a “natural experiment,” in which two otherwise similar groups of people are divided by one circumstance — often a policy change or social program. U.S. military members receiving treatment from military facilities can't sue their military physicians or facilities for medical malpractice. However, the authors claim that military personnel can also opt to receive private care outside of a military base. This, they say, generates two pools of otherwise similar people, divided by their two care options — one with no liability for doctors, and one with liability. The idea for doing a study based on this comparison occurred to Gruber while he was working with the Military Health Service on other healthcare delivery issues.
&#nl
“For decades, health economists have been searching to find the holy grail of a natural experiment to tell us what would happen if people couldn’t sue for malpractice,” Gruber said.
&#nl
The study examines Military Health System data on 1,016,606 births in military families, from 2003 to 2013. About 44% of the deliveries occurred at military health facilities and 56% at civilian hospitals. Ultimately, as the study shows, C-sections are about 4% more common during the deliveries at military hospitals, compared to the times when mothers in the Military Health System deliver at civilian hospitals.
&#nl
Gruber says that finding will seem unexpected to those who associate defensive medicine with an increase in operations, treatment, and interventions.
&#nl
“We tend to think of defensive medicine as … doctors doing extra testing because they’re afraid of getting sued,” he says. But this finding indicates that, in childbirth settings, doctors practice defensive medicine by intervening slightly less.
&#nl
For more on this study and an earlier paper by Gruber and  Frakes, check out the full MIT News story.
"
  ["description"]=>
  string(3976) "&#nl
During childbirth, are doctors more likely or less likely to intervene surgically if liability is a concern? A study co-authored by an economist at Massachusetts of Technology (MIT) and a professor of law and economics at the Duke University, offers insight on this interesting question about "defensive medicine."
&#nl
The research, based on evidence from the U.S. Military Health System, finds that when doctors have immunity from liability lawsuits, they actually perform slightly more C-section operations, compared to when they are legally liable for those operations — about 4% more, over a 10-year period.
&#nl
“When you’re worried about errors of commission, defensive medicine can lead to [less] treatment of patients,” said Jonathan Gruber, an MIT economist and co-author of a new paper detailing the study’s findings.
&#nl
The paper, “Defensive Medicine and Obstetric Practices: Evidence from the Military Health System,” is published this month in the Journal of Empirical Legal Studies. Gruber's co-author is Michael Frakes, a professor of law and economics at the Duke University School of Law.
&#nl
According to the paper, 74% of obstetricians and gynecologists face malpractice claims by age 45, compared to 55% of physicians in the area of internal medicine.
&#nl
To conduct the study, Gruber and Frakes used Military Health System data to conduct what economists call a “natural experiment,” in which two otherwise similar groups of people are divided by one circumstance — often a policy change or social program. U.S. military members receiving treatment from military facilities can't sue their military physicians or facilities for medical malpractice. However, the authors claim that military personnel can also opt to receive private care outside of a military base. This, they say, generates two pools of otherwise similar people, divided by their two care options — one with no liability for doctors, and one with liability. The idea for doing a study based on this comparison occurred to Gruber while he was working with the Military Health Service on other healthcare delivery issues.
&#nl
“For decades, health economists have been searching to find the holy grail of a natural experiment to tell us what would happen if people couldn’t sue for malpractice,” Gruber said.
&#nl
The study examines Military Health System data on 1,016,606 births in military families, from 2003 to 2013. About 44% of the deliveries occurred at military health facilities and 56% at civilian hospitals. Ultimately, as the study shows, C-sections are about 4% more common during the deliveries at military hospitals, compared to the times when mothers in the Military Health System deliver at civilian hospitals.
&#nl
Gruber says that finding will seem unexpected to those who associate defensive medicine with an increase in operations, treatment, and interventions.
&#nl
“We tend to think of defensive medicine as … doctors doing extra testing because they’re afraid of getting sued,” he says. But this finding indicates that, in childbirth settings, doctors practice defensive medicine by intervening slightly less.
&#nl
For more on this study and an earlier paper by Gruber and  Frakes, check out the full MIT News story.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "40"
  ["rss_id"]=>
  string(2) "40"
  [14]=>
  string(73) "https://www.mddionline.com/what-if-we-couldnt-sue-our-doctors-malpractice"
  ["blog_url"]=>
  string(73) "https://www.mddionline.com/what-if-we-couldnt-sue-our-doctors-malpractice"
  [15]=>
  string(19) "2020-03-19 02:54:10"
  ["add_date"]=>
  string(19) "2020-03-19 02:54:10"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:33"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8366"
  ["article_id"]=>
  string(4) "8366"
  [1]=>
  string(62) "Using 'organs-on-a-chip' to model complicated diseases"
  ["article_title"]=>
  string(62) "Using 'organs-on-a-chip' to model complicated diseases"
  [2]=>
  string(150) "Biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system on a micro"
  ["short_description"]=>
  string(150) "Biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system on a micro"
  [3]=>
  string(331) "Biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system on a microfluidic chip seeded with human cells. With this 'organs-on-a-chip' model, they could explore the role of immune cells in ulcerative colitis and other inflammatory diseases. "
  ["description"]=>
  string(331) "Biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system on a microfluidic chip seeded with human cells. With this 'organs-on-a-chip' model, they could explore the role of immune cells in ulcerative colitis and other inflammatory diseases. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200318143758.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200318143758.htm"
  [15]=>
  string(19) "2020-03-19 02:37:58"
  ["add_date"]=>
  string(19) "2020-03-19 02:37:58"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:16"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8394"
  ["article_id"]=>
  string(4) "8394"
  [1]=>
  string(59) "Novel system allows untethered high-quality multi-player VR"
  ["article_title"]=>
  string(59) "Novel system allows untethered high-quality multi-player VR"
  [2]=>
  string(150) "Researchers created a new approach to VR that will allow multiple players to interact with the same VR app on smartphones and provide new opportunitie"
  ["short_description"]=>
  string(150) "Researchers created a new approach to VR that will allow multiple players to interact with the same VR app on smartphones and provide new opportunitie"
  [3]=>
  string(198) "Researchers created a new approach to VR that will allow multiple players to interact with the same VR app on smartphones and provide new opportunities for education, health care and entertainment. "
  ["description"]=>
  string(198) "Researchers created a new approach to VR that will allow multiple players to interact with the same VR app on smartphones and provide new opportunities for education, health care and entertainment. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "34"
  ["rss_id"]=>
  string(2) "34"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200318143735.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200318143735.htm"
  [15]=>
  string(19) "2020-03-19 02:37:35"
  ["add_date"]=>
  string(19) "2020-03-19 02:37:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:24"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8395"
  ["article_id"]=>
  string(4) "8395"
  [1]=>
  string(64) "Supercomputers unlock reproductive mysteries of viruses and life"
  ["article_title"]=>
  string(64) "Supercomputers unlock reproductive mysteries of viruses and life"
  [2]=>
  string(150) "Supercomputer simulations support a new mechanism for the budding off of viruses like the coronavirus. ESCRTIII polymer features clear intrinsic twist"
  ["short_description"]=>
  string(150) "Supercomputer simulations support a new mechanism for the budding off of viruses like the coronavirus. ESCRTIII polymer features clear intrinsic twist"
  [3]=>
  string(360) "Supercomputer simulations support a new mechanism for the budding off of viruses like the coronavirus. ESCRTIII polymer features clear intrinsic twist in molecular dynamics simulations, might play major role in creating three-dimensional buckling of the cell membrane. Related study used simulations to find mechanism for DNA base addition during replication. "
  ["description"]=>
  string(360) "Supercomputer simulations support a new mechanism for the budding off of viruses like the coronavirus. ESCRTIII polymer features clear intrinsic twist in molecular dynamics simulations, might play major role in creating three-dimensional buckling of the cell membrane. Related study used simulations to find mechanism for DNA base addition during replication. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "34"
  ["rss_id"]=>
  string(2) "34"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200318143653.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200318143653.htm"
  [15]=>
  string(19) "2020-03-19 02:36:53"
  ["add_date"]=>
  string(19) "2020-03-19 02:36:53"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:25"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8367"
  ["article_id"]=>
  string(4) "8367"
  [1]=>
  string(49) "Maggot analysis goes molecular for forensic cases"
  ["article_title"]=>
  string(49) "Maggot analysis goes molecular for forensic cases"
  [2]=>
  string(150) "Maggots on a dead body or wound can help pinpoint when a person or animal died, or when maltreatment began in elder, child care or animal neglect case"
  ["short_description"]=>
  string(150) "Maggots on a dead body or wound can help pinpoint when a person or animal died, or when maltreatment began in elder, child care or animal neglect case"
  [3]=>
  string(439) "Maggots on a dead body or wound can help pinpoint when a person or animal died, or when maltreatment began in elder, child care or animal neglect cases. However, the current process for making this determination is time consuming and resource intensive. It also relies on species assessment by trained entomologists. Now, researchers report the development of a molecular maggot analysis method that's quick, easy and less subjective. "
  ["description"]=>
  string(439) "Maggots on a dead body or wound can help pinpoint when a person or animal died, or when maltreatment began in elder, child care or animal neglect cases. However, the current process for making this determination is time consuming and resource intensive. It also relies on species assessment by trained entomologists. Now, researchers report the development of a molecular maggot analysis method that's quick, easy and less subjective. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200318143643.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200318143643.htm"
  [15]=>
  string(19) "2020-03-19 02:36:43"
  ["add_date"]=>
  string(19) "2020-03-19 02:36:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:16"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8427"
  ["article_id"]=>
  string(4) "8427"
  [1]=>
  string(78) "BD Ramps Up Production, Collaborates on New Diagnostic in Response to COVID-19"
  ["article_title"]=>
  string(78) "BD Ramps Up Production, Collaborates on New Diagnostic in Response to COVID-19"
  [2]=>
  string(153) "&#nlBD (Becton, Dickinson and Company) was one of several medtech companies that joined President Donald Trump when he declared a national emergency last"
  ["short_description"]=>
  string(153) "&#nlBD (Becton, Dickinson and Company) was one of several medtech companies that joined President Donald Trump when he declared a national emergency last"
  [3]=>
  string(3445) "&#nl
BD (Becton, Dickinson and Company) was one of several medtech companies that joined President Donald Trump when he declared a national emergency last week. Several medtech executives detailed their response to the novel coronavirus (COVID-19) pandemic.
&#nl
Tom Polen, BD’s CEO and president, reported during President Trump’s announcement that BD is “one of the leading providers of medical devices as well as collection products for testing of coronavirus and we are ramping up our manufacturing capacity to ensure that the right collection devices and testing equipment are ready to address this issue.”
&#nl
BD reported later that it’s ramping up production of its sample collection tools and increasing access to its automated molecular platform for in vitro diagnostics. A BD spokesperson told MD+DI that “The manufacturing facility that makes our collection devices is running 24/7 with ramped up production and we will be supplying hundreds of thousands of swabs/collection devices to the U.S. market every week.”
&#nl
This week BD announced a collaboration with molecular diagnostics company BioGX Inc. in which the two companies have submitted Emergency Use Authorization requests (EUA) to the U.S. FDA for new COVID-19 diagnostic tests to be run on the BD MAX Molecular Diagnostic Platform, a system already used by hundreds of U.S laboratories. The automated unit can process samples in under three hours. If FDA grants the EUA, the new testing capability could handle thousands of tests per day, BD reported.
&#nl
"The collaboration with BioGX to deliver a COVID-19 diagnostic in the U.S. is another example of BD's commitment to help with the global COVID-19 pandemic and combat the spread of infectious diseases," said Nikos Pavlidis, vice president and general manager, molecular diagnostics and women's health for BD, in a statement. "Our BD MAX System is a versatile molecular platform that enables us to rapidly deliver molecular solutions across our laboratory customers and help communities in need during times of high anxiety."
&#nl
BioGX developed the assay for the BD MAX System in a ready-to-use format for detecting the presence of the SARS-CoV-2 virus, the cause of COVID-19, it was reported in the statement. The assay is based on the same viral RNA targeting sequences and real-time PCR detection method as the test developed by the U.S. Centers for Disease Control and Prevention (CDC), it was reported. Stated Shazi Iqbal, Ph.D., BioGX CEO, in the statement: "Authorization to use our test would increase access across the U.S. to an automated, highly reliable SARS-CoV-2 test."
&#nl
Another BD product could play a role in point-of-care testing. The BD Veritor system, which is currently being used to test for other respiratory infections including Influenza A, Influenza B, RSV, and group A Streptococcus, is being considered for development of a point-of-care test for coronavirus, BD reported.
"
  ["description"]=>
  string(3445) "&#nl
BD (Becton, Dickinson and Company) was one of several medtech companies that joined President Donald Trump when he declared a national emergency last week. Several medtech executives detailed their response to the novel coronavirus (COVID-19) pandemic.
&#nl
Tom Polen, BD’s CEO and president, reported during President Trump’s announcement that BD is “one of the leading providers of medical devices as well as collection products for testing of coronavirus and we are ramping up our manufacturing capacity to ensure that the right collection devices and testing equipment are ready to address this issue.”
&#nl
BD reported later that it’s ramping up production of its sample collection tools and increasing access to its automated molecular platform for in vitro diagnostics. A BD spokesperson told MD+DI that “The manufacturing facility that makes our collection devices is running 24/7 with ramped up production and we will be supplying hundreds of thousands of swabs/collection devices to the U.S. market every week.”
&#nl
This week BD announced a collaboration with molecular diagnostics company BioGX Inc. in which the two companies have submitted Emergency Use Authorization requests (EUA) to the U.S. FDA for new COVID-19 diagnostic tests to be run on the BD MAX Molecular Diagnostic Platform, a system already used by hundreds of U.S laboratories. The automated unit can process samples in under three hours. If FDA grants the EUA, the new testing capability could handle thousands of tests per day, BD reported.
&#nl
"The collaboration with BioGX to deliver a COVID-19 diagnostic in the U.S. is another example of BD's commitment to help with the global COVID-19 pandemic and combat the spread of infectious diseases," said Nikos Pavlidis, vice president and general manager, molecular diagnostics and women's health for BD, in a statement. "Our BD MAX System is a versatile molecular platform that enables us to rapidly deliver molecular solutions across our laboratory customers and help communities in need during times of high anxiety."
&#nl
BioGX developed the assay for the BD MAX System in a ready-to-use format for detecting the presence of the SARS-CoV-2 virus, the cause of COVID-19, it was reported in the statement. The assay is based on the same viral RNA targeting sequences and real-time PCR detection method as the test developed by the U.S. Centers for Disease Control and Prevention (CDC), it was reported. Stated Shazi Iqbal, Ph.D., BioGX CEO, in the statement: "Authorization to use our test would increase access across the U.S. to an automated, highly reliable SARS-CoV-2 test."
&#nl
Another BD product could play a role in point-of-care testing. The BD Veritor system, which is currently being used to test for other respiratory infections including Influenza A, Influenza B, RSV, and group A Streptococcus, is being considered for development of a point-of-care test for coronavirus, BD reported.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "40"
  ["rss_id"]=>
  string(2) "40"
  [14]=>
  string(92) "https://www.mddionline.com/bd-ramps-production-collaborates-new-diagnostic-response-covid-19"
  ["blog_url"]=>
  string(92) "https://www.mddionline.com/bd-ramps-production-collaborates-new-diagnostic-response-covid-19"
  [15]=>
  string(19) "2020-03-19 01:04:15"
  ["add_date"]=>
  string(19) "2020-03-19 01:04:15"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:33"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8286"
  ["article_id"]=>
  string(4) "8286"
  [1]=>
  string(45) "What Works Best to Ease the Pain of Sciatica?"
  ["article_title"]=>
  string(45) "What Works Best to Ease the Pain of Sciatica?"
  [2]=>
  string(157) "WEDNESDAY, March 18, 2020 -- Surgery can cut pain intensity by more than half among patients struggling with long-term sciatica, researchers report.&#nl""
  ["short_description"]=>
  string(157) "WEDNESDAY, March 18, 2020 -- Surgery can cut pain intensity by more than half among patients struggling with long-term sciatica, researchers report.&#nl""
  [3]=>
  string(258) "WEDNESDAY, March 18, 2020 -- Surgery can cut pain intensity by more than half among patients struggling with long-term sciatica, researchers report.&#nl"Sciatica is the symptom of pain that radiates down the leg and is caused by compression of a nerve..."
  ["description"]=>
  string(258) "WEDNESDAY, March 18, 2020 -- Surgery can cut pain intensity by more than half among patients struggling with long-term sciatica, researchers report.&#nl"Sciatica is the symptom of pain that radiates down the leg and is caused by compression of a nerve..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(158) "https://www.drugs.com/news/works-best-ease-pain-sciatica-89041.html?utm_source=ddc&utm_medium=rss&utm_campaign=What+Works+Best+to+Ease+the+Pain+of+Sciatica%3F"
  ["blog_url"]=>
  string(158) "https://www.drugs.com/news/works-best-ease-pain-sciatica-89041.html?utm_source=ddc&utm_medium=rss&utm_campaign=What+Works+Best+to+Ease+the+Pain+of+Sciatica%3F"
  [15]=>
  string(19) "2020-03-19 01:03:25"
  ["add_date"]=>
  string(19) "2020-03-19 01:03:25"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:28:42"
  ["create_at"]=>
  string(19) "2020-03-19 11:28:42"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8449"
  ["article_id"]=>
  string(4) "8449"
  [1]=>
  string(51) "Pharma events update: rescheduled, canceled, online"
  ["article_title"]=>
  string(51) "Pharma events update: rescheduled, canceled, online"
  [2]=>
  string(109) "This list includes the industry events that have been postponed or moved because of the coronavirus pandemic."
  ["short_description"]=>
  string(109) "This list includes the industry events that have been postponed or moved because of the coronavirus pandemic."
  [3]=>
  string(109) "This list includes the industry events that have been postponed or moved because of the coronavirus pandemic."
  ["description"]=>
  string(109) "This list includes the industry events that have been postponed or moved because of the coronavirus pandemic."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(143) "https://www.outsourcing-pharma.com/Article/2020/03/18/Pharma-events-affected-by-coronavirus?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(143) "https://www.outsourcing-pharma.com/Article/2020/03/18/Pharma-events-affected-by-coronavirus?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-18 23:39:00"
  ["add_date"]=>
  string(19) "2020-03-18 23:39:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:40"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8462"
  ["article_id"]=>
  string(4) "8462"
  [1]=>
  string(71) "Health Catalyst unveils two systems and a service for COVID-19 response"
  ["article_title"]=>
  string(71) "Health Catalyst unveils two systems and a service for COVID-19 response"
  [2]=>
  string(153) "The healthcare analytics vendor's systems and service are focused on patient tracking, public health surveillance and staff-augmentation support.&#nl"
  ["short_description"]=>
  string(153) "The healthcare analytics vendor's systems and service are focused on patient tracking, public health surveillance and staff-augmentation support.&#nl"
  [3]=>
  string(153) "The healthcare analytics vendor's systems and service are focused on patient tracking, public health surveillance and staff-augmentation support.&#nl"
  ["description"]=>
  string(153) "The healthcare analytics vendor's systems and service are focused on patient tracking, public health surveillance and staff-augmentation support.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(103) "https://www.healthcareitnews.com/news/health-catalyst-unveils-two-systems-and-service-covid-19-response"
  ["blog_url"]=>
  string(103) "https://www.healthcareitnews.com/news/health-catalyst-unveils-two-systems-and-service-covid-19-response"
  [15]=>
  string(19) "2020-03-18 23:38:37"
  ["add_date"]=>
  string(19) "2020-03-18 23:38:37"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:44"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8448"
  ["article_id"]=>
  string(4) "8448"
  [1]=>
  string(47) "Fujifilm Diosynth to create biocampus in the UK"
  ["article_title"]=>
  string(47) "Fujifilm Diosynth to create biocampus in the UK"
  [2]=>
  string(150) "Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapie"
  ["short_description"]=>
  string(150) "Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapie"
  [3]=>
  string(164) "Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapies development."
  ["description"]=>
  string(164) "Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapies development."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(150) "https://www.outsourcing-pharma.com/Article/2020/03/18/Fujifilm-Diosynth-builds-biocampus-in-the-UK?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(150) "https://www.outsourcing-pharma.com/Article/2020/03/18/Fujifilm-Diosynth-builds-biocampus-in-the-UK?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-18 23:31:00"
  ["add_date"]=>
  string(19) "2020-03-18 23:31:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:34:40"
  ["create_at"]=>
  string(19) "2020-03-19 11:34:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8472"
  ["article_id"]=>
  string(4) "8472"
  [1]=>
  string(67) "Sanofi, Regeneron start late-stage trials for coronavirus treatment"
  ["article_title"]=>
  string(67) "Sanofi, Regeneron start late-stage trials for coronavirus treatment"
  [2]=>
  string(136) "Sanofi and Regeneron begin recruitment for a Phase II/III trial evaluating an existing product as a potential treatment for coronavirus."
  ["short_description"]=>
  string(136) "Sanofi and Regeneron begin recruitment for a Phase II/III trial evaluating an existing product as a potential treatment for coronavirus."
  [3]=>
  string(136) "Sanofi and Regeneron begin recruitment for a Phase II/III trial evaluating an existing product as a potential treatment for coronavirus."
  ["description"]=>
  string(136) "Sanofi and Regeneron begin recruitment for a Phase II/III trial evaluating an existing product as a potential treatment for coronavirus."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(164) "https://www.biopharma-reporter.com/Article/2020/03/18/Sanofi-and-Regeneron-advance-candidate-against-coronavirus?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(164) "https://www.biopharma-reporter.com/Article/2020/03/18/Sanofi-and-Regeneron-advance-candidate-against-coronavirus?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-18 23:26:00"
  ["add_date"]=>
  string(19) "2020-03-18 23:26:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-19 11:35:12"
  ["create_at"]=>
  string(19) "2020-03-19 11:35:12"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}